Closed consultation

Proposal to make Nasonex Allergy Control Nasal Spray available without prescription.

We are analysing your feedback

Visit this page again soon to download the outcome to this public feedback.

Original consultation

This consultation ran from to

Summary

We want to know what you think about our proposal to Nasonex Allergy Control Nasal Spray available without prescription.

Documents

Nasonex Allergy Control 0.05% Nasal Spray Public Consultation

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Response to Nasonex Allergy Control 0.05% Nasal Spray Public Consultation - Word version

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Consultation description

We want to know what you think

  • Nasonex Allergy Control 0.05% Nasal Spray is used to treat the symptoms of hayfever (also called seasonal allergic rhinitis) and perennial allergic rhinitis (this occurs throughout the year).
  • Nasonex Allergy Control is only at the moment available on prescription.
  • We propose to make it available in pharmacies.
  • MHRA considers that this product can be available as a Pharmacy medicine.
  • We want to know what you think about this change.

Please tell us your views using the form at the end of the attached pdf.

The deadline for comments is 12 December 2016.